A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.
作者:
主题词
儿童(Child);儿童行为障碍(Child Behavior Disorders);儿童发育障碍, 广泛性(Child Development Disorders, Pervasive);儿童, 学龄前(Child, Preschool);认知障碍(Cognition Disorders);剂量效应关系, 药物(Dose-Response Relationship, Drug);兴奋性氨基酸拮抗剂(Excitatory Amino Acid Antagonists);女(雌)性(Female);谷氨酸(Glutamic Acid);人类(Humans);智力(Intelligence);语言发展障碍(Language Development Disorders);男(雄)性(Male);美金刚(Memantine);记忆障碍(Memory Disorders);神经心理学测验(Neuropsychological Tests);前瞻性研究(Prospective Studies);治疗结果(Treatment Outcome)
DOI
10.1089/cap.2006.16.517
PMID
17069541
发布时间
2013-11-21
- 浏览7
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文